LWW lands The Cancer Journal

Share this article:
Wolters Kluwer Health has picked up The Cancer Journal from Jones & Bartlett.

The journal will be published by Lippincott Williams & Wilkins under the new name The Cancer Journal: The Journal of Principles and Practices of Oncology.

Jeff McCaulley, president and CEO of Wolters Kluwer Health, said: “The acquisition of The Cancer Journal is congruent with our strategy to grow our leading positions by extending our proprietary content in the healthcare industry, especially in leading disease states and therapeutic areas.”

LWW also publishes The Journal of Clinical Oncology, Annals of Oncology and Cancer Nursing.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...